The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 77 | 13.4x | 20.1x | Above average | |
Growth | 76 | 19.9% | 5.6% | Above average | |
Quality | 81 | 114.4% | 7.6% | Above average | |
Safety | 60 | -0.6x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Collegium Pharmaceutical, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Collegium Pharmaceutical, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Collegium Pharmaceutical stock shows complete stability in its target price at $58 over the past 7 and 30-day periods, with a significant gap between the current price ($34.07) and the average target, indicating high optimism from the covering analyst. However, institutional uncertainty is evident given the decrease in the number of analysts updating current price forecasts to only one, compared to greater momentum in historical financial estimate data.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.